“… - Box Bounding ( Netzeva et al., 2005 )
- Convex Hull ( Jaworska et al., 2005 )
- DM ( Sheridan et al., 2004 )
- SDC score ( Liu et al., 2018 )
- NNAS ( Allen et al., 2020 )
| - Virtual screening ( Berenger and Yamanishi, 2019 )
- Anticancer peptide activity prediction ( Chen et al., 2021 )
- SARS-CoV 2 inhibitor prediction ( Gawriljuk et al., 2021 )
- Toxicity prediction ( Jiang et al., 2021 )
| Bayesian | Parameters and outputs are treated as random variables and maximum a posteriori (MAP) estimation is adopted according to Bayes’ theorem. | - VI (MC-dropout) ( Gal and Ghahramani, 2016 )
- BNN ( Goan and Fookes, 2020 )
- GP-MGK ( Xiang et al., 2021 )
- MVE ( Nix and Weigend, 1994 )
- Bayesian GCN ( Ryu et al., 2019 )
| - Molecular property prediction ( Zhang and Lee, 2019 )
- Virtual screening ( Ryu et al., 2019 )
- Protein-ligand interaction prediction ( Kim et al., 2021 )
|
Ensemble-based | The consistency of the predictions from various base models is an estimate of confidence. | - Bootstrapping ( Scalia et al., 2020 )
- RF ( Sheridan, 2012 )
- DeltaDelta ( Jimenez-Luna et al., 2019 )
- Deep ensemble ( Lakshminarayanan et al., 2017 )
- MC-dropout ( Gal and Ghahramani, 2016 )
| - Drug-likeness prediction ( Beker et al., 2020 )
- Molecular property prediction ( Scalia et al., 2020 ) ...
|
…”